Patient Care

At UC San Francisco, we don’t just treat diseases, we treat individuals. We put our patients’ priorities at the center of our care, and strive for breakthrough discoveries so that we can improve people’s lives.

Research

UC San Francisco is leading revolutions in health – and those revolutions often start in the lab. From basic science to clinical research, we are constantly pushing scientific boundaries and earning worldwide recognition for our discoveries.

Education

At UC San Francisco, we encourage our students to approach health care issues with critical thinking and a spirit of inquiry. As tomorrow’s health and science leaders in training, UCSF students embody our passion for improving the human condition and pushing health care forward.

Support UCSF

As the leading university focused exclusively on health, UC San Francisco is advancing health worldwide. Whether you contribute your time or your money, you are helping to progress knowledge in medicine and drive scientific breakthroughs to create a healthier world.

You are here

Home > UCSF News Center > Two UCSF Scientists on Forbes Magazine's "30 Under 30" List of Brightest Young Stars

Two UCSF Scientists on Forbes Magazine's "30 Under 30" List of Brightest Young Stars

December 20, 2011

Mozziyar Etemadi, an MD/PhD candidate in Bioengineering,

UCSF scientists Mozziyar Etemadi, an MD/PhD candidate in Bioengineering, and James Fraser, PhD, a postdoctoral scholar in structural biology, are featured in Forbes magazine’s first ever “30 Under 30” list of rising stars in science and innovation.

“These are the people who aren't waiting to reinvent the world,” the editors wrote in the special edition, posted Dec. 19, 2011. They are “making a difference right now.”

Etemadi, 25, a graduate student in the Department of Bioengineering & Therapeutic Sciences, was recognized for developing a device that detects pre-term labor in high-risk pregnancies and alerts the patient’s physician via a cloud database. He received the 2011 mHealth Alliance Award for this work. More broadly, Etemadi is focused on designing pediatric biomedical devices and biomedical instruments to enable doctors to monitor patients’ progress in their homes or remote clinical settings.

James Fraser, PhD, a postdoctoral scholar in structural biology

Fraser, 29, a fellow in the Department of Cellular & Molecular Pharmacology, was recognized for using computation and biophysics to discover mutations that cause disease. One of 10 recipients to date of the National Institutes of Health's prestigious Early Independence Awards, in honor of his “exceptional scientific creativity and productivity,” he developed methods to study the molecular structure of proteins – the most important element in determining how, or whether, that protein will work in the body. Those methods have vast applications in research and drug discovery and are now being used, among other research, to study drug resistance among people infected with HIV.

The UCSF scientists’ fellow “stars” include Daniela Witten, at University of Washington, who is developing artificial intelligence programs that decipher how genes lead to disease, Rizia Bardham, at Lawrence Berkeley National Laboratory, who is developing nanotech particles that can diagnose or treat disease, and Albert Mach, at University of California, Los Angeles, who is developing a centrifuge on a chip that could provide a rapid way to detect cancer via a blood test.

The science and technology list, assembled with input from geneticist and cardiologist Eric Topol of the Scripps Research Institute, physicist Lisa Randall of Harvard University, and genomics technologist Stephen Quake of Stanford, was culled from hundreds of nominations.